Real-World Safety and Efficacy of 156 U – 195 U OnabotulinumtoxinA in Adults With Chronic Migraine: Results From the REPOSE Study
NCT01686581. Name of registry: ClinicalTrials.gov. URL of registry: Date of retrospective registration: September 18, 2012. Date of enrolment of first patient: July 23, 2012.
Authors
- Fayyaz Ahmed (ORCID: https://orcid.org/0000-0002-2746-0889)
- Ritu Singh
- Charly Gaul (ORCID: https://orcid.org/0000-0002-9362-3711)
- Katja Kollewe
- Katherine Sommer (ORCID: https://orcid.org/0000-0001-5622-5872)
Institutions
- University of Erfurt (DE)
- AbbVie (United States) (US)
- Medizinische Hochschule Hannover (DE)
Publication Details
- Journal
- BMC Neurology
- Published
- 2025-05-06
- DOI
- https://doi.org/10.1186/s12883-025-04087-7
- Primary Topic
- Migraine and Headache Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00